nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—hematologic cancer	0.292	0.667	CbGaD
Oxtriphylline—HDAC2—Vorinostat—hematologic cancer	0.17	0.41	CbGbCtD
Oxtriphylline—PDE3A—Anagrelide—hematologic cancer	0.156	0.375	CbGbCtD
Oxtriphylline—PDE4B—hematologic cancer	0.146	0.333	CbGaD
Oxtriphylline—CYP1A2—Anagrelide—hematologic cancer	0.0175	0.0422	CbGbCtD
Oxtriphylline—CYP1A2—Carmustine—hematologic cancer	0.00921	0.0222	CbGbCtD
Oxtriphylline—SLC22A7—Methotrexate—hematologic cancer	0.00833	0.0201	CbGbCtD
Oxtriphylline—CYP1A2—Methoxsalen—hematologic cancer	0.00783	0.0189	CbGbCtD
Oxtriphylline—CYP1A2—Bortezomib—hematologic cancer	0.00745	0.0179	CbGbCtD
Oxtriphylline—CYP1A2—Daunorubicin—hematologic cancer	0.00713	0.0172	CbGbCtD
Oxtriphylline—CYP1A2—Alitretinoin—hematologic cancer	0.00698	0.0168	CbGbCtD
Oxtriphylline—CYP1A2—Thalidomide—hematologic cancer	0.00649	0.0156	CbGbCtD
Oxtriphylline—CYP1A2—Dacarbazine—hematologic cancer	0.00558	0.0134	CbGbCtD
Oxtriphylline—CYP1A2—Imatinib—hematologic cancer	0.00546	0.0132	CbGbCtD
Oxtriphylline—CYP1A2—Dasatinib—hematologic cancer	0.00438	0.0106	CbGbCtD
Oxtriphylline—CYP1A2—Etoposide—hematologic cancer	0.00273	0.00658	CbGbCtD
Oxtriphylline—PDE3B—hematopoietic system—hematologic cancer	0.00214	0.0529	CbGeAlD
Oxtriphylline—ADORA2A—hematopoietic system—hematologic cancer	0.00148	0.0364	CbGeAlD
Oxtriphylline—PDE3B—blood—hematologic cancer	0.00142	0.035	CbGeAlD
Oxtriphylline—PDE3B—bone marrow—hematologic cancer	0.00137	0.0339	CbGeAlD
Oxtriphylline—PDE3A—hematopoietic system—hematologic cancer	0.00131	0.0323	CbGeAlD
Oxtriphylline—ADORA1—hematopoietic system—hematologic cancer	0.00128	0.0315	CbGeAlD
Oxtriphylline—HDAC2—hematopoietic system—hematologic cancer	0.00126	0.0311	CbGeAlD
Oxtriphylline—PDE3B—lung—hematologic cancer	0.00124	0.0307	CbGeAlD
Oxtriphylline—ADORA2B—blood—hematologic cancer	0.00118	0.029	CbGeAlD
Oxtriphylline—PDE3B—testis—hematologic cancer	0.00117	0.029	CbGeAlD
Oxtriphylline—ADORA2A—gonad—hematologic cancer	0.00112	0.0277	CbGeAlD
Oxtriphylline—PDE4D—lung—hematologic cancer	0.00104	0.0256	CbGeAlD
Oxtriphylline—ADORA2B—lung—hematologic cancer	0.00103	0.0254	CbGeAlD
Oxtriphylline—PDE4D—testis—hematologic cancer	0.00098	0.0242	CbGeAlD
Oxtriphylline—ADORA2A—blood—hematologic cancer	0.000978	0.0241	CbGeAlD
Oxtriphylline—ADORA2B—testis—hematologic cancer	0.000973	0.024	CbGeAlD
Oxtriphylline—HDAC2—gonad—hematologic cancer	0.000958	0.0236	CbGeAlD
Oxtriphylline—PDE4B—hematopoietic system—hematologic cancer	0.000943	0.0233	CbGeAlD
Oxtriphylline—HDAC2—Topotecan—Irinotecan—hematologic cancer	0.000941	0.494	CbGdCrCtD
Oxtriphylline—PDE4A—lung—hematologic cancer	0.000919	0.0227	CbGeAlD
Oxtriphylline—PDE4A—testis—hematologic cancer	0.000867	0.0214	CbGeAlD
Oxtriphylline—PDE3A—blood—hematologic cancer	0.000867	0.0214	CbGeAlD
Oxtriphylline—PDE3B—lymph node—hematologic cancer	0.000851	0.021	CbGeAlD
Oxtriphylline—HDAC2—blood—hematologic cancer	0.000834	0.0206	CbGeAlD
Oxtriphylline—ADORA2A—testis—hematologic cancer	0.000809	0.02	CbGeAlD
Oxtriphylline—HDAC2—bone marrow—hematologic cancer	0.000807	0.0199	CbGeAlD
Oxtriphylline—SLC22A7—testis—hematologic cancer	0.000802	0.0198	CbGeAlD
Oxtriphylline—Caffeine—ATM—hematologic cancer	0.000784	0.179	CrCbGaD
Oxtriphylline—PDE3A—lung—hematologic cancer	0.00076	0.0188	CbGeAlD
Oxtriphylline—ADORA1—lung—hematologic cancer	0.000741	0.0183	CbGeAlD
Oxtriphylline—HDAC2—lung—hematologic cancer	0.000732	0.0181	CbGeAlD
Oxtriphylline—Caffeine—PIK3CD—hematologic cancer	0.000717	0.163	CrCbGaD
Oxtriphylline—Caffeine—PIK3CB—hematologic cancer	0.000717	0.163	CrCbGaD
Oxtriphylline—PDE4B—gonad—hematologic cancer	0.000717	0.0177	CbGeAlD
Oxtriphylline—PDE3A—testis—hematologic cancer	0.000717	0.0177	CbGeAlD
Oxtriphylline—PDE4D—lymph node—hematologic cancer	0.00071	0.0175	CbGeAlD
Oxtriphylline—ADORA1—testis—hematologic cancer	0.000699	0.0172	CbGeAlD
Oxtriphylline—HDAC2—testis—hematologic cancer	0.00069	0.017	CbGeAlD
Oxtriphylline—PDE4A—lymph node—hematologic cancer	0.000628	0.0155	CbGeAlD
Oxtriphylline—PDE4B—blood—hematologic cancer	0.000625	0.0154	CbGeAlD
Oxtriphylline—PDE4B—bone marrow—hematologic cancer	0.000605	0.0149	CbGeAlD
Oxtriphylline—CYP1A2—hematopoietic system—hematologic cancer	0.000579	0.0143	CbGeAlD
Oxtriphylline—Theophylline—HDAC2—hematologic cancer	0.000578	0.131	CrCbGaD
Oxtriphylline—Caffeine—PIK3CA—hematologic cancer	0.000555	0.126	CrCbGaD
Oxtriphylline—PDE4B—lung—hematologic cancer	0.000548	0.0135	CbGeAlD
Oxtriphylline—HDAC2—Menadione—Thalidomide—hematologic cancer	0.000541	0.284	CbGdCrCtD
Oxtriphylline—PDE3A—lymph node—hematologic cancer	0.00052	0.0128	CbGeAlD
Oxtriphylline—PDE4B—testis—hematologic cancer	0.000517	0.0128	CbGeAlD
Oxtriphylline—ADORA1—lymph node—hematologic cancer	0.000507	0.0125	CbGeAlD
Oxtriphylline—HDAC2—lymph node—hematologic cancer	0.0005	0.0123	CbGeAlD
Oxtriphylline—HDAC2—Teniposide—Etoposide—hematologic cancer	0.000424	0.223	CbGdCrCtD
Oxtriphylline—Dyphylline—PDE4B—hematologic cancer	0.000405	0.0922	CrCbGaD
Oxtriphylline—CYP1A2—blood—hematologic cancer	0.000384	0.00947	CbGeAlD
Oxtriphylline—PDE4B—lymph node—hematologic cancer	0.000375	0.00925	CbGeAlD
Oxtriphylline—CYP1A2—lung—hematologic cancer	0.000336	0.0083	CbGeAlD
Oxtriphylline—Theophylline—PDE4B—hematologic cancer	0.000289	0.0657	CrCbGaD
Oxtriphylline—Caffeine—PDE4B—hematologic cancer	0.000283	0.0645	CrCbGaD
Oxtriphylline—Caffeine—ABCB1—hematologic cancer	6.48e-05	0.0147	CrCbGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFB1—hematologic cancer	2.91e-06	2.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTEN—hematologic cancer	2.91e-06	2.91e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—IDH1—hematologic cancer	2.9e-06	2.91e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP3—hematologic cancer	2.9e-06	2.9e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL2—hematologic cancer	2.89e-06	2.89e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—hematologic cancer	2.89e-06	2.89e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—hematologic cancer	2.89e-06	2.89e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MYC—hematologic cancer	2.89e-06	2.89e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—STAT3—hematologic cancer	2.89e-06	2.89e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NRAS—hematologic cancer	2.88e-06	2.88e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SRC—hematologic cancer	2.88e-06	2.88e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—hematologic cancer	2.88e-06	2.88e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGF2—hematologic cancer	2.87e-06	2.88e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCC3—hematologic cancer	2.87e-06	2.87e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TXN—hematologic cancer	2.87e-06	2.87e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTO1—hematologic cancer	2.87e-06	2.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—STAT3—hematologic cancer	2.86e-06	2.86e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP3—hematologic cancer	2.86e-06	2.86e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL2—hematologic cancer	2.86e-06	2.86e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NRAS—hematologic cancer	2.86e-06	2.86e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—hematologic cancer	2.84e-06	2.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK8—hematologic cancer	2.84e-06	2.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—hematologic cancer	2.84e-06	2.84e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	2.83e-06	2.84e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3R1—hematologic cancer	2.83e-06	2.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SRC—hematologic cancer	2.83e-06	2.83e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTEN—hematologic cancer	2.83e-06	2.83e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCND1—hematologic cancer	2.82e-06	2.82e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—JUN—hematologic cancer	2.81e-06	2.82e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SPHK1—hematologic cancer	2.81e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAP2K1—hematologic cancer	2.81e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—hematologic cancer	2.8e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CD—hematologic cancer	2.79e-06	2.79e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCND1—hematologic cancer	2.79e-06	2.79e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—JUN—hematologic cancer	2.78e-06	2.78e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—STAT3—hematologic cancer	2.78e-06	2.78e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EP300—hematologic cancer	2.77e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NRAS—hematologic cancer	2.77e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	2.77e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.76e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	2.76e-06	2.76e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—hematologic cancer	2.76e-06	2.76e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MAPK3—hematologic cancer	2.76e-06	2.76e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—JAK2—hematologic cancer	2.75e-06	2.76e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK3—hematologic cancer	2.74e-06	2.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—KRAS—hematologic cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—STAT3—hematologic cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CDKN1A—hematologic cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NRAS—hematologic cancer	2.72e-06	2.73e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTEN—hematologic cancer	2.72e-06	2.72e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—UGT1A1—hematologic cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EP300—hematologic cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CDKN1A—hematologic cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SRC—hematologic cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KRAS—hematologic cancer	2.69e-06	2.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTEN—hematologic cancer	2.69e-06	2.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MDM2—hematologic cancer	2.69e-06	2.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MYC—hematologic cancer	2.68e-06	2.68e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFB1—hematologic cancer	2.68e-06	2.68e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGF2—hematologic cancer	2.67e-06	2.67e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK8—hematologic cancer	2.66e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MYC—hematologic cancer	2.66e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—hematologic cancer	2.66e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFB1—hematologic cancer	2.65e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK3—hematologic cancer	2.65e-06	2.65e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3R1—hematologic cancer	2.63e-06	2.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK8—hematologic cancer	2.63e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.63e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC22A1—hematologic cancer	2.63e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—hematologic cancer	2.63e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—hematologic cancer	2.62e-06	2.63e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SRC—hematologic cancer	2.62e-06	2.62e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CB—hematologic cancer	2.62e-06	2.62e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MTOR—hematologic cancer	2.62e-06	2.62e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK3—hematologic cancer	2.61e-06	2.61e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—STAT3—hematologic cancer	2.6e-06	2.6e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EP300—hematologic cancer	2.6e-06	2.6e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NRAS—hematologic cancer	2.59e-06	2.59e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MYC—hematologic cancer	2.58e-06	2.58e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFB1—hematologic cancer	2.57e-06	2.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EP300—hematologic cancer	2.56e-06	2.57e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—JAK2—hematologic cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	2.55e-06	2.56e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MYC—hematologic cancer	2.54e-06	2.54e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFB1—hematologic cancer	2.53e-06	2.53e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—STAT3—hematologic cancer	2.53e-06	2.53e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SRC—hematologic cancer	2.52e-06	2.53e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NRAS—hematologic cancer	2.52e-06	2.52e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.51e-06	2.51e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MDM2—hematologic cancer	2.5e-06	2.5e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SRC—hematologic cancer	2.49e-06	2.5e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK3—hematologic cancer	2.48e-06	2.49e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NUP98—hematologic cancer	2.48e-06	2.48e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KRAS—hematologic cancer	2.48e-06	2.48e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PIK3CA—hematologic cancer	2.47e-06	2.48e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—hematologic cancer	2.46e-06	2.46e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KRAS—hematologic cancer	2.46e-06	2.46e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CDKN1B—hematologic cancer	2.45e-06	2.46e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—STAT3—hematologic cancer	2.43e-06	2.44e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CB—hematologic cancer	2.43e-06	2.43e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MTOR—hematologic cancer	2.43e-06	2.43e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—hematologic cancer	2.43e-06	2.43e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NRAS—hematologic cancer	2.43e-06	2.43e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	2.42e-06	2.42e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MYC—hematologic cancer	2.42e-06	2.42e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFB1—hematologic cancer	2.41e-06	2.41e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.41e-06	2.41e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.41e-06	2.41e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP3—hematologic cancer	2.41e-06	2.41e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—STAT3—hematologic cancer	2.41e-06	2.41e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL2—hematologic cancer	2.4e-06	2.4e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NRAS—hematologic cancer	2.4e-06	2.4e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—hematologic cancer	2.39e-06	2.4e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NUP214—hematologic cancer	2.39e-06	2.39e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KRAS—hematologic cancer	2.38e-06	2.39e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.37e-06	2.37e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MYC—hematologic cancer	2.35e-06	2.35e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KRAS—hematologic cancer	2.34e-06	2.35e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	2.34e-06	2.35e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCND1—hematologic cancer	2.34e-06	2.34e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTR—hematologic cancer	2.34e-06	2.34e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.34e-06	2.34e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—JUN—hematologic cancer	2.34e-06	2.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK3—hematologic cancer	2.33e-06	2.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—hematologic cancer	2.32e-06	2.32e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK3—hematologic cancer	2.3e-06	2.3e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO2—hematologic cancer	2.3e-06	2.3e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—hematologic cancer	2.29e-06	2.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN1B—hematologic cancer	2.28e-06	2.28e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PIK3CA—hematologic cancer	2.28e-06	2.28e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CDKN1A—hematologic cancer	2.27e-06	2.27e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MYC—hematologic cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTEN—hematologic cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PIK3CA—hematologic cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—hematologic cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFB1—hematologic cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP3—hematologic cancer	2.24e-06	2.24e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MYC—hematologic cancer	2.23e-06	2.24e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL2—hematologic cancer	2.23e-06	2.23e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KRAS—hematologic cancer	2.23e-06	2.23e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	2.23e-06	2.23e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.23e-06	2.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—hematologic cancer	2.22e-06	2.22e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK8—hematologic cancer	2.21e-06	2.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.19e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—hematologic cancer	2.19e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PIK3CA—hematologic cancer	2.19e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—hematologic cancer	2.18e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCND1—hematologic cancer	2.18e-06	2.18e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SDC1—hematologic cancer	2.18e-06	2.18e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—JUN—hematologic cancer	2.17e-06	2.17e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KRAS—hematologic cancer	2.17e-06	2.17e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EP300—hematologic cancer	2.16e-06	2.16e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PIK3CA—hematologic cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—hematologic cancer	2.12e-06	2.12e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—hematologic cancer	2.11e-06	2.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN1A—hematologic cancer	2.11e-06	2.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTEN—hematologic cancer	2.1e-06	2.1e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SRC—hematologic cancer	2.1e-06	2.1e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KRAS—hematologic cancer	2.09e-06	2.09e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—hematologic cancer	2.09e-06	2.09e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—hematologic cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.08e-06	2.08e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KRAS—hematologic cancer	2.07e-06	2.07e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK8—hematologic cancer	2.06e-06	2.06e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.05e-06	2.05e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PIK3CA—hematologic cancer	2.05e-06	2.05e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—hematologic cancer	2.05e-06	2.05e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—hematologic cancer	2.04e-06	2.04e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—hematologic cancer	2.03e-06	2.03e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—STAT3—hematologic cancer	2.02e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—hematologic cancer	2.02e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NRAS—hematologic cancer	2.02e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—hematologic cancer	2.02e-06	2.02e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EP300—hematologic cancer	2e-06	2.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—hematologic cancer	2e-06	2e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—hematologic cancer	2e-06	2e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	1.99e-06	2e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—hematologic cancer	1.99e-06	1.99e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—hematologic cancer	1.98e-06	1.99e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.96e-06	1.96e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SRC—hematologic cancer	1.95e-06	1.95e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—hematologic cancer	1.94e-06	1.94e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK3—hematologic cancer	1.93e-06	1.93e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—hematologic cancer	1.93e-06	1.93e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	1.92e-06	1.92e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—hematologic cancer	1.91e-06	1.91e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—hematologic cancer	1.9e-06	1.9e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	1.9e-06	1.9e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—hematologic cancer	1.9e-06	1.9e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—STAT3—hematologic cancer	1.88e-06	1.88e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MYC—hematologic cancer	1.88e-06	1.88e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NRAS—hematologic cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFB1—hematologic cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—hematologic cancer	1.86e-06	1.86e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—hematologic cancer	1.86e-06	1.86e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NQO1—hematologic cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CD44—hematologic cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—hematologic cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—hematologic cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—hematologic cancer	1.84e-06	1.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—hematologic cancer	1.82e-06	1.82e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.81e-06	1.81e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK3—hematologic cancer	1.8e-06	1.8e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—hematologic cancer	1.79e-06	1.79e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—hematologic cancer	1.78e-06	1.78e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—hematologic cancer	1.77e-06	1.77e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—hematologic cancer	1.76e-06	1.76e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—hematologic cancer	1.76e-06	1.76e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYCS—hematologic cancer	1.75e-06	1.75e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MYC—hematologic cancer	1.75e-06	1.75e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFB1—hematologic cancer	1.74e-06	1.74e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.74e-06	1.74e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KRAS—hematologic cancer	1.74e-06	1.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—hematologic cancer	1.7e-06	1.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—hematologic cancer	1.68e-06	1.68e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—hematologic cancer	1.68e-06	1.68e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—hematologic cancer	1.63e-06	1.63e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KRAS—hematologic cancer	1.61e-06	1.61e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CA—hematologic cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—hematologic cancer	1.57e-06	1.57e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.57e-06	1.57e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—hematologic cancer	1.55e-06	1.55e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.54e-06	1.54e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—hematologic cancer	1.54e-06	1.54e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.49e-06	1.49e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.48e-06	1.48e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—hematologic cancer	1.48e-06	1.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.46e-06	1.46e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—hematologic cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.42e-06	1.42e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.42e-06	1.42e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—hematologic cancer	1.41e-06	1.41e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—hematologic cancer	1.37e-06	1.37e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—hematologic cancer	1.31e-06	1.31e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—hematologic cancer	1.3e-06	1.3e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.25e-06	1.25e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—hematologic cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.05e-06	1.05e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.77e-07	9.77e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	9.26e-07	9.27e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALB—hematologic cancer	9.14e-07	9.15e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.74e-07	8.75e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	8.07e-07	8.08e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTEN—hematologic cancer	6.97e-07	6.98e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—EP300—hematologic cancer	6.65e-07	6.66e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.92e-07	4.92e-06	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—hematologic cancer	4.02e-07	4.02e-06	CbGpPWpGaD
